Dr. Immaculata De Vivo is Professor of Medicine at Harvard Medical School and Professor of Epidemiology at the Harvard School of Public Health as well as Co-Director of the Science Program at the Radcliffe Institute for Advanced Studies. Dr. De Vivo is an international leader in the area of molecular and genetic epidemiology of cancer. Her research focuses on how the environment interacts with genetic variants to influence susceptibility to hormonal cancers. Her laboratory focuses primarily on the discovery and characterization of genetic biological markers to assess disease susceptibility in human populations. This approach has been applied to understanding the etiology of endometrial (EC) and other hormonal cancers. Her lab also has experience in conducting whole-genome association studies and exome wide association studies (GWAS/EWAS). As a Co-leader and co-founder of the NCI-sponsored international endometrial cancer consortium (E2C2) she led the effort identifying all known genetic loci predisposing to EC. Dr. De Vivo is also a leader in the field of telomere biology. Her work has added tremendous insight to the role of telomeres in cancer etiology. One of her most clinically relevant findings involved hematologic cancers. This study provides evidence of a survival benefit associated with longer donor LTL in patients transplanted for Severe Aplastic Anemia. Because telomere length has both genetic and environmental determinants she has also demonstrated how lifestyle choices can delay or accelerate telomere shortening. A specific example is her work with telomeres and adherence to the Mediterranean diet. Her finding that adherence to a Mediterranean diet, published in British Medical Journal, can delay telomere shortening was particularly notable for its broad implications that DNA can be modified by lifestyle choices. It was recognized by scientific community with awards for her work exploring the molecular mechanism by which the Mediterranean diet improves longevity. It was also recognized by the lay community with extensive press coverage including CNN, NYT, Forbes. She is the Director of the Dana Farber/Harvard Cancer Center Genotyping and Genetics for Population Sciences Facility, and the Editor-In-Chief of the internationally recognized journal Cancer Causes and Control.